Transcript

Benign disease as a margin stabilizer. · Medsolve Dynamics

Yoel Bakas: Benign disease is getting attention for a reason. We are talking about osteoarthritis, plantar fasciitis, and degenerative joint pain. At ACRO this year, benign disease was positioned as a stabilizer under reimbursement pressure. That is accurate. but volume does not appear automatically. It requires new referral patterns, clear inclusion criteria, protocol discipline, and dedicated scheduling blocks. If the referral behavior doesn't change, machine utilization will also not change. Benign disease can work when it's engineered, not when it's assumed. The new volumes require structure.